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ABSTRACT
Addition of glycolipids obtained from Salmonella minnesota R mutants to normal, spontane-
ously transformed, and SV40-transformed rat embryo fibroblasts in culture results in an
inhibition of growth of transformed cells but not of normal cells. In the presence of the
glycolipid with the smallest carbohydrate chain length, spontaneously transformed cells
stop growing when they reach confluency . Inhibition of growth of transformed cells is in-
versely related to the chain length of the core sugars . Glycolipid mR595 is shown to bind
with the cell membrane of transformed cells and elicits an augmentation in the intracellular
level of cyclic AMP. Normal cells bind relatively less glycolipid mR595 and show a lower
percent of increase in cyclic AMP due to glycolipid mR595 than do transformed cells.
INTRODUCTION
Transformed cells are characterized by loss of
control mechanisms regulating ordered growth in
normal cells. This loss results in multilayered
growth of transformed cells in vitro and in un-
limited growth, metastasis, and invasiveness in
vivo. During the past years, it has been proposed
(1, 2, 3, 4) that these characteristics of trans-
formed cells depend upon alterations in cell
surface/cell membrane constituents after trans-
formation of normal cells. More recently, agglu-
tination of transformed cells by low concentrations
of plant lectins is cited as an indication of mem-
brane alteration (5, 6, 7) . Normal cells are not
agglutinated by the same concentration of lectin .
Although the exact mechanism of agglutination
is not known, it is well established that specific
sugar residues on the cell surface are involved in
interaction with plant lectins (8) . Interaction of
trypsinized jack bean lectin (concanavalin A)
with cultured cells has also been employed to
control growth of polyoma transformed cells (9) .
Prompted by the above studies showing that
plant agglutinins can be employed as probes for
cell surface studies and can also inhibit growth of
transformed cells, we have employed another
group of substances, namely bacterial glyco-
lipids, because of their known ability to bind cell
membranes of red blood cells (10) and their
damaging action on transplanted tumors (11-15) .
In an initial study, one of us (V . N. Nigam) ob-
served that injection of glycolipids obtained from
R mutants of Salmonella minnesota into mice bearing
Ehrlich solid tumor significantly increased their
survival time. It was also observed that bacterial
glycolipids of shorter length of core sugars were
increasingly more effective, whereas glycolipids
from wild-type S. minnesota were ineffective . On
the basis of these preliminary findings, we have
now carried out complementary studies on bac-
terial glycolipids utilizing normal and transformed
rat embryo fibroblasts in cultures . This paper
reports the effects of various glycolipids obtained
from S. minnesota R mutants on the growth of
normal and transformed cells, on the binding of
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cells, and on the probable mechanism (an in-
crease in intracellular cyclic AMP concentration)
by which the glycolipid elicits its inhibitory effect
on transformed cell growth .
MATERIALS AND METHODS
Cells
Primary rat embryo fibroblasts (ER) were obtained
by trypsinization of 15-day old Wistar rat embryos
(pregnant females were secured from Flow Labora-
tories, Rockville, Md.). Cells were employed after one
subculture.
Spontaneously transformed cells (RST) are an
established cell line which developed spontaneously
from rat embryonic cultures.
SV40-transformed cell line (RSV40) is a cell line
obtained after transformation of rat embryo cultures
by SV40 virus. These cells carry SV40 T antigen .
Both spontaneously transformed and SV40-trans-
formed cell lines grow in multilayers, grow in soft
agar, and induce tumors in rats.
Growth of Cell Cultures
Cells were cultivated in minimum essential me-
dium (MEM, Flow Laboratories), supplemented with
10(/'o fetal calf serum (Flow Laboratories), 10%J o tryp-
tose phosphate broth (Difco Laboratories, Inc ., De-
troit, Mich.), fourfold the concentration of vitamins
and amino acids, L-glutamine (10 mg/ml), penicillin
(200 µg/ml), and streptomycin (40 ug/ml) . The
cultures were prepared in roller flasks . Cells were
subcultivated at a concentration of 1 .2 X 106
cells/Petri dish in Falcon Petri dishes (Falcon Plastics,
Division of B-D Laboratories, Inc., Los Angeles,
Calif.) (60 mm diameter) in 4 ml medium and placed
in an air-CO2 incubator (5% C02). To study the
TABLE I
Structure of the Four Glycolipids Used in the Experiments
Name
	
Structure
effect on the growth of these cells, known amounts of
bacterial glycolipids and dibutyryl cyclic AMP were
added to 24-h old cell cultures after dissolution of the
substances in appropriate medium. Cells were
counted initially and after every 24 h in a hemo-
cytometer (Biirker, Karl Hecht, Bayern, West Ger-
many) after trypsinization .
Viability of Cells
The viability of cells grown in the presence of
bacterial glycolipids or dibutyryl cyclic AMP was
established by two different methods . One of these
was the dye exclusion test (16), and the other, the
plating efficiency of cells (17). The plating efficiency
of the cells was determined by plating 50, 100, 200,
500, and 1,000 cells/Petri dish (60 mm, Falcon
Plastics) and 1 wk later the cells were fixed in alco-
hol and stained with Unna-blue . The number of
colonies, their size, and the number of cells per col-
ony were counted.
Growth in Agar
To study the effect on the growth of transformed
cells in agar, cells were grown in agar medium con-
taining glycolipid mR595 . The procedure of growth
in agar is described by Montagnier and MacPherson
(18).
Bacterial Glycolipids
Glycolipids from S. minnesota R mutants were kindly
supplied by Dr. O. Lilderitz, hMax-Planck-Institut
fur Immunbiologie, Freiburg, Germany. The known
features of their structures are given in Table I .
Tritium labeled bacterial glycolipid mR595 was
prepared as follows : heptose-less mutant of S. minne-
sota (provided by Dr. O. Liideritz) was grown in a
nutrient broth medium (Difco Antibacterial Me-
mR595
	
(KDO)3-lipid A
mR7
	
Hep-Hep-(KDO)3-lipid A
mR5
	
Glc-Hep-Hep-(KDO)3-lipid A
mR60
	
G1cNac-Glc-Gal-Glc-Hep-Hep-(KDO)-Lipid A
Gal P,ETN
Abbreviations : ETN, ethanolamine ; Gal, galactose; Glc, glucose ; G1cNac, N-acetyl-
glucosamine; Hep, L-glycero-D-mannoheptose ; KDO, 2-keto-3-deoxyoctonic acid ;
lipid A, glucosaminyl-/(3-1,6-glucosamine with fatty acid substituted to hydroxyl and
amino groups (Fatty acids found in lipid A are /3-hydroxymyristic acid, myristic acid,
palmitic acid, and lauric acid.) ; P, phosphate.
BRAILovsiy, TRuDFL, LALLIER, AND NIGAM Lipopolysaccharide Effect on Growth
	
125dium 3) . It was sedimented and washed in a syn-
thetic salt medium (19) . 1-2 ml of packed bacteria
were suspended in 10 ml of the above synthetic
medium and 25 ,uCi of n-[6-3H]glucosamine (sp
act 1-2 Ci mmol, New England Nuclear Corp .,
Boston, Mass.) and 100 mg of unlabeled fructose
were added. The suspension was kept at 37 °C for
30 min with shaking, and later the cells were washed
twice with water, and the glycolipid was isolated
from the bacteria as described by Galanos et al . (20).
The yield of the glycolipid was 1-3°%0 of the dry
weight of bacteria, and the specific activity among
various batches varied from 60,000 to 100,000
cpm/mg of glycolipid.
Uptake of Labeled Glycolipid by
Cultured Cells
The cells were trypsinized for 15 min at 37 °C,
washed twice with the complete growth medium, and
resuspended in the same medium at a concentration
of 1 .2 X 106 cells/4 ml. 0.10 ml of a 200 µg/ml
solution of the labeled glycolipid mR595 was then
added and the cell suspension was incubated for
15 min at 37°C with shaking. The cells were sedi-
mented by centrifugation, washed twice with phos-
phate-buffered saline (PBS)), and dissolved in
Aquasol. They were counted in a liquid scintillation
spectrometer (Nuclear-Chicago Mark 1, Nuclear-
Chicago, Des Plaines, Ill .). For studying the uptake
of glycolipid in growing cells, the labeled glycolipid
solution (0.1 ml containing 20 µg) was added to
Petri dishes, 24 h after the cells had been in culture .
Every subsequent 24 h the cells were scraped with a
rubber policeman and treated as described above for
counting their radioactivity.
Demonstration of Cell Surface
Binding of Glycolipid mR595
by Immunofluorescence
Cells were grown in Leighton tubes for 24 h and
were later washed in PBS . They were fixed in
methanol and dried. A few drops of a solution of
glycolipid mR595 (200 µg/ml) were added to the
fixed cells during 20 min at room temperature. The
fixed cells were washed with physiological saline
and dried. To these mR595-coated cells, 1 or 2 drops
of anti-mR595 rabbit antiserum (21) was added
and the cells were incubated for 1 h at 35°C. The cells
were washed with physiological saline, dried, and
treated with 1 or 2 drops of fluorescein-conjugated
sheep antirabbit globulin antiserum (Difco Labora-
tories, Inc.) for 45 min at 35°C. After this incubation
the cells were washed in PBS, and visualized under
a fluorescence microscope.
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Cyclic AMP Determination
The technique employed was a modification of
that described by Broustad et al. (22). Cells were in-
cubated in the presence or absence of glycolipid
mR595. 24 h later, 1.5 µCi of [14C]adenine (6.83
mCi/mmole, New England Nuclear Corp .) was
added to the cultures (1 h at 37 °C). The cells were
washed three times with PBS, scraped from the
Petri dishes with a rubber policeman, and homogen-
ized (Vortex homogenizer) with 1 ml 0.1 N HCI
followed by centrifugation (15 min, 3,000 rpm) .
The recovery was determined by adding a known
amount of [3H]cyclic AMP. 0.10 ml of the super-
natant was spotted on Whatman paper no. 1 .
After 12 h of migration (solvent : 96% ethanol,
2 M NH4OH, 2 M acetic acid, 100 19 21, vol/vol/
vol), the cyclic AMP band was cut out, eluted with
I ml of 0.5 N HCI, and the radioactivity was counted
in a liquid scintillation spectrometer.
RESULTS
Effects of Various Bacterial Glycolipids
on Growth of Cultured Cells
In Fig. 1 the effects of four glycolipids (mR595,
mR7, mR5, and mR60) on the growth of normal,
spontaneously transformed, and SV40-transformed
rat embryo fibroblasts are shown . Growth of
normal cells seeded at a concentration of 0 .4 X
106 cells/Petri dish was not affected by these
glycolipids during their five cycles of cell division .
Fig. 1 a represents the growth of normal cells
seeded at a concentration of 1 .2 X 106 cells/Petri
dish in order to compare with the growth charac-
teristics of transformed cells. In contrast, spon-
taneously transformed cells (Fig . 1 b) show an
inhibition of growth which varies according to
the nature of the bacterial glycolipid. It is inter-
esting to note that the order of decreasing inhi-
bition of growth by glycolipids is : mR595 >
mR7 > mR5 > mR60, which represents the
increasing chain length. This is also true for SV40-
transformed cells although SV40-transformed cells
(Fig. 1 c) are relatively less sensitive to inhibition
than spontaneously transformed rat embryo
fibroblasts.
Apparently one can observe two types of effects
of the bacterial glycolipids on spontaneously trans-
formed cells. The first consists in an inhibition of
cell growth after their addition, and the second
seems to relate to cessation of growth which
becomes explicit after the cell cultures reach a
certain density. These effects are less pronounced2 6- X
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in virally transformed cells, although they do
exist in their case as well .
Since glycolipid mR595 was the most effective
growth inhibitor for spontaneously transformed
cells, we studied the effect of its concentrations on
the growth of spontaneously transformed rat
embryo fibroblasts (Fig . 2). It was observed that
the inhibition was dose dependent within the range
of 0.1-5 µg glycolipid/ml medium. Increase in
the concentration to 20 .sg/m1 failed to elicit an
inhibition greater than that observed with 5
µg/ml (Fig. 2) .
Growth of Cells in Agar
It is known that transformed cells have the
ability to grow in agar whereas the normal cells
fail to do so. As a corollary to the above experiment
we tried the effect of mR595 on the growth of
spontaneously and virally transformed rat embryo
fibroblasts in agar medium. It was observed that
the presence of the bacterial glycolipid signifi-
cantly inhibited the growth of these cells in agar .
O
	
6-
x
J J
U 5-
3-
2-
O
1
	
2
	
3
	
4
	
5
	
1
	
2
	
3
	
4
	
5
	
1
	
2
	
3
	
4
	
5
DAYS
	
DAYS
	
DAYS
FIGURE 1 Effects of a single addition of glycolipid mR595 (O), mR7 (A), mR5 (o), and mR60 (A) on the
growth of normal (ER) (1 a), spontaneously transformed (RST) (1 b), and SV40-transformed (RSV40)
(1 c) rat embryo fibroblasts, added 24 h after seeding . The controls are represented by closed squares .
The glycolipids were dissolved in PBS by heating at 100 °C for 15 min, to give a concentration of 200
µg/ml. 0.10 ml of the solution was added to 4 ml of the culture medium contained in the Petri dishes
seeded with the cells. To the controls, 0 .1 ml of PBS was added . Each point represents an average value
obtained with 30 Petri dishes. The following t values have been obtained denoting significance of the re-
sults; t is considered significant when t < 0.05 : (Fig. I a) mR595 0.20 < t < 0.30, mR7 0.30 < t < 0.50,
mR5 0.30 < t <0.50, mR60 0.50 < t < 0.90; (Fig. 1 b) mR595 t < 0.001, mR7 t < 0.001, mR5 t <
0.001, MR60 t < 0.001 ; (Fig. 1 c) mR595 t < 0.001, mR7 t < 0.001, mR5 t < 0.001, mR60 0.001 <
t < 0.01.
Lack of Cytotoxic Effect of Bacterial
Glycolipid mR595 on Cultured Cells
The morphology of cells (both normal and
transformed) remained unaltered when they were
treated with glycolipid mR595 . The cells remained
viable as demonstrated by exclusion of trypan
blue by the treated cells. A more vigorous assay
of viability was performed by estimating the plat-
ing efficiency of glycolipid mR595-treated and
untreated cells. It was observed that the plating
efficiency of both spontaneously transformed and
SV40-transformed cells was the same in the pres-
ence and absence of glycolipid mR595 . The only
difference was that the colonies that formed in
the presence of mR595 were smaller.
Uptake of Glycolipid mR595
Table II shows the uptake of the labeled glyco-
lipid mR595 when it was added to cultured
normal and transformed cells for 15 min, 24 h,
and 48 h. It was observed that 15 min of exposure
BRAILOVSKY, TRUDEL, LALLIER, AND NIGAM Lipopolysaccharide Effect on Growth
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FIGURE 2 Effect of different concentrations of gly-
colipid mR595 on the growth of spontaneously trans-
formed rat embryo fibroblasts (RST). 0.10 ml of dif-
ferent concentrations of glycolipid mR595 dissolved
in PBS by heating at 100°C for 15 min was added to
Petri dishes seeded 24 h earlier with spontaneously
transformed cells and containing 4 ml of the culture
medium. /, PBS (control) ; p, 0.1 Ag/ml; A, 1 ,ug/ml;
/L, 5 µg/ml; o, 10 µg/ml; •, 20 µg/ml. Each point
on the figure represents an average value obtained
with 30 Petri dishes. The t values denoting the signifi-
cance of the results are as follows : 0.1,ug/ml, 0.001 <
t < 0.01; 1 µg/ml, t < 0.001 ; 5 ,ug/ml, t < 0.001;
10 pg/ml, t < 0.001; 20 µg/ml, t < 0.001. The t
value between 5 yg/ml and 20 µg/ml (0.10 < t <
0.20) indicates no significant difference between
these concentrations .
gave no uptake by normal cells, but exposure for
24 h elicited some uptake which decreased if the
glycolipid was left for 48 h in the culture medium .
On the other hand, both transformed cells ex-
hibited small uptake during 15 min of exposure
which increased considerably after 24 h . This up-
take was not decreased after an additional 24 h of
exposure in the case of spontaneously transformed
cells and decreased 45% in the case of virally
transformed cells.
When both normal and transformed cells were
trypsinized (15 min at 37°C) and the detached
cells suspended in the complete growth medium,
addition of labeled glycolipid mR595 gave an
increased uptake during 15 min of exposure of the
three types of cells (Table II, column 5). The most
dramatic increase was in the case of normal rat
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embryo fibroblasts which took up the same amount
of glycolipid as the virally transformed cells . Simi-
larly, neuraminidase treatment gave increased
uptake (experiments done in case of RST cells
only) . The uptake of the glycolipid by untryp-
sinized spontaneously and virally transformed
cells was not removed by trypsin treatment
(Table II, column 2).
Fixation of Glycolipid mR595
on Cell Membrane
In order to show cell surface binding, the three
kinds of cells were grown in tubes for 24 h and
fixed in methanol for immunofluorescence assay
(see Materials and Methods). It was observed
that normal rat embryo fibroblasts showed very
little fluorescence (Fig. 3 a), whereas both trans-
formed cell lines (Fig. 3 b, 3 c) exhibit strong
fluorescence at the cell surface.
Role of Cyclic AMP and Glycolipid
mR595 on Growth
During the course of our work on bacterial
glycolipid action on growth, a number of investi-
gators reported (23-26) that cyclic AMP and
dibutyryl cyclic AMP alone or with theophylline
inhibit growth of cells and alter the morphology
and agglutination characteristics of transformed
cells. It appeared to us reasonable to think that
glycolipid action may be mediated in a manner
similar to dibutyryl cyclic AMP plus theophylline
action reported for transformed 3T3 cells by Shep-
pard (26). In case both glycolipid and dibutyryl
cyclic AMP plus theophylline increase the intra-
cellular concentration of cyclic AMP to the same
extent, the addition of the two together should not
induce an additive effect on the inhibition of
growth of the transformed cells. The results from
such an experiment are shown in Fig. 4. It is
apparent from Fig. 4 that both glycolipid and
dibutyryl cyclic AMP give a similar pattern of
growth inhibition of spontaneously transformed
cells. When they are added together there is
slightly greater inhibition only during the two
initial days of growth. Subsequently, we carried
out an estimation of cyclic AMP in normal and
transformed cells, with and without the treatment
of cells with glycolipid mR595 for 24 h. We ob-
served (Table III) that the cyclic AMP level
was highest in normal cells, that it was about
half of this value for spontaneously transformedcells, and that it was lowest in SV40-transformed
cells. 24 h after the addition of glycolipid mR595,
the level of cyclic AMP was increased about 35%
in the case of normal cells, and it was augmented
to the level of normal cells in the case of spontane-
ously transformed cells and to half the level of
normal cells in the case of SV40-transformed
cells.
DISCUSSION
Factors that regulate the growth of transformed
cells without affecting normal cells are apparently
at the heart of the problem of control of neoplasia .
During the past 3 yr reports have appeared show-
ing that certain substances such as trypsinized
concanavalin A (9), dibutyryl cyclic AMP (23),
dibutyryl cyclic AMP plus theophylline (26), and
dibutyryl cyclic AMP plus testosterone (27) alter
the growth pattern of certain transformed cells
such that these treated cells revert back to the
growth pattern of normal cells. This reversion is
expressed as long as the additive is present in the
culture medium. Although we initially embarked
on the action of bacterial glycolipids with the in-
tention of showing their specific cytotoxic action
on cancer cells, the results have demonstrated that
bacterial glycolipids at the concentrations we have
TABLE II
Uptake of Labeled Glycolipid mR595 by Normal and Transformed Cells
(ug of mR595 bound/ 106 cells)
The labeled glycolipid mR595 and the cell culture were prepared as described in Materials and Methods.
For the 15 min uptake the glycolipid mR595 (5 µg/ml) was added directly in the cell culture medium .
After 15 min at 37°C the cells were washed three times with PBS . Some samples were resuspended in
trypsin (0.10 0) and kept at 37°C for 15 min, and washed three times with PBS . In the second case of up-
take, the labeled glycolipid mR595 (2 pg glycolipid/1 .2 X 106 cells/4 ml medium) was added to Petri
dishes 24 h after the cells had been in culture . Every subsequent 24 h, the cells were scraped with a rubber
policeman and washed three times with PBS. For the last case of uptake, the cells were treated with trypsin
or neuraminidase for 15 min at 37°C, washed twice with the complete growth medium, and resuspended
in the same medium at a concentration of 1 .2 X 106 cells/4 ml. 0.10 ml of a 200 µg/ml solution of the labeled
glycolipid mR595 was then added, and the cell suspension was incubated for 15 min at 37 °C with shaking.
The cells were sedimented by centrifugation, and then were washed three times with PBS . For radio-
activity determination, the cells were dissolved in Aquasol . They were counted in a liquid scintillation
spectrometer. The values are an average t the standard deviation obtained in three experiments . In each
experiment, 10 Petri dishes were taken .
used are not cytotoxic. On the other hand, they
show a tendency to inhibit the growth of trans-
formed cells. Our observations with bacterial
glycolipids differ from those with trypsinized
concanavalin A and with dibutyryl cyclic AMP
in certain respects. First, unlike trypsinized con-
canavalin A, bacterial glycolipids inhibit growth
immediately after their addition to the culture
medium rather than inhibit growth only when
transformed cells reach confluency, and secondly,
unlike cyclic AMP, the glycolipids have not been
observed to cause any morphological alterations in
cells treated with them.
One of the interesting features of our results is
the demonstration that the inhibitory action of
bacterial glycolipids is a function of the carbo-
hydrate chain length . The smallest carbohydrate
chain length is the most effective, whereas longer
chain length of core sugars (as in mR60) is the
least effective in inhibiting growth. This is in
accord with the experiments of one of us (V . N .
Nigam) where survival times of animals bearing
Ehrlich solid tumor are also increased when the
same glycolipids with gradually shorter core length
are used.
We have also observed that the growth of spon-
taneously transformed cells is more effectively in-
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Type of cells
Time of binding
15 min
15 min uptake
followed by
trypsinization 24 h
	
48 h
Trypsinized cells
exposed to mR595
for 15 min
Neuraminidase-treated
cells exposed to mR595
for 15 min
ER 0 0 0 .69 f 0 .10 0 .29 f 0 .05 4 .7 f 0 .50
RST 0.74 ± 0 .33 0 .44 f 0 .11 2 .90 f 0.60 3.28 f 0.40 9 .12 f 1 .28 7 .57 t 0 .82
RSV40 0.65 ± 0.11 0 .54 ± 0 .05 4 .28 f 0 .75 2 .25 f 0 .80 5 .14 t 0 .65FIGURE 3 Fluorescence pattern of normal (a), spontaneously transformed (RST) (b), and SV40-trans-
formed rat embryo fibroblasts (RSV40) (c). The figure shows an indirect immunofluorescence assay
for the binding of glycolipid mR595 on transformed cells . Normal cells show poor fluorescence. Details
of the experimental procedure are provided in Materials and Methods . Fig. 3 a, X 500 ; Fig. 3 b, X 320,
Fig. 3 c, X 500.-5-
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FIGURE 4 Effects of dibutyryl cyclic AMP + theo-
phylline(A), glycolipid mR595(i ), and a mixture
of dibutyryl cyclic, AMP, theophylline, and glycolipid
mR595(p) on the growth of spontaneously transformed
rat embryo fibroblasts (RST) . Dibutyryl cyclic AMP
and theophylline were added after dissolution in
PBS (0.1 ml) to give a final concentration of 0 .1 mM
and 1 mM/Petri dish, respectively. To the control
(N), 0.2 ml of PBS was added. The conditions of the
experiment were the same as described in Figs . 1 and
2. Each point in the figure represents an average value
obtained with 30 Petri dishes; t is considered signifi-
cant when the value is less than 5% (0.05 > t) : mR595,
0.001 > t; cAMP, 0.001 > t; mR595 - cAMP,
0.001 > t; cyclic AMP with mR595 - cAMP, 0.20 >
I > 0.10.
hibited by certain glycolipids (mR595, mR5, and
mR7) than that of virally transformed cells . How-
ever, the significance of this result must await
further testing with a variety of spontaneously
and virally transformed cell lines.
The action of bacterial glycolipid mR595 seems
to be mediated by its initial interaction with the
cell membrane. From the binding data with 3H-
labeled glycolipid mR595, it appeared that un-
treated normal cells lack some receptor sites for
the glycolipid whereas transformed cells have these
sites. This has not been found true. The fixation of
the glycolipid on normal cell membrane seems to
be hindered by the presence of sialic acid . The
sialic acid in question is the glycoprotein sialic
acid, since trypsin which removes glycopeptides
also allows free access of glycolipid to the cell
membrane, and its uptake by the cell . In fact it
has been observed that protein-bound sialic acid
is lower in transformed cells as compared to
normal cells. On the other hand, ganglioside sialic
TABLE III
Alteration in Intracellular Cyclic AMP
Concentration by Glycolipid mR595
Details of the determination of cyclic AMP are
described in Materials and Methods.
acid is the same in normal and spontaneously
transformed cells and is lower in virally trans-
formed cells. Quantitatively the uptake of glyco-
lipid mR595 after trypsinization of the cells differs
between the three kinds of cells, insofar as normal
cells show least uptake, whereas spontaneously
transformed cells show nearly double that amount.
How far this difference could be responsible for
growth inhibition is difficult to assess at the present
time.
Although experiments with 3H-labeled glyco-
lipid mR595 can only be described as experiments
demonstrating uptake, immunological experiments
suggest that the glycolipid is in fact bound to the
cell surface and/or cell membrane . We tend to
believe that the glycolipid binds to the lipid bi-
layer of the membrane since the lipid group of the
bacterial glycolipid would have greater affinity for
lipids of the cell membrane, and secondly, we have
seen that bound glycolipid is not removed from the
cells even if they are treated with trypsin . In this
respect, the binding of bacterial glycolipid with
cells differs from that of concanavalin A, which is
known to bind with cell surface glycoprotein-
hexose. Thus, in our case the cryptic nature of
bacterial glycolipid binding sites on normal cells is
due to cell surface glycoprotein, whereas in the
case of concanavalin A-mediated agglutination of
normal cells it is due to possible exposure of masked
hexose residues of glycoprotein on mild trypsin
treatment. Further, in our case transformed cells
appear to have certain regions of exposed cell
membrane (not recovered by glycoprotein),
whereas normal cells have very few or none . In
both cases, trypsin treatment uncovers areas so
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131
Cyclic AMP (pmol/mg proteins)
Expt no.
Type of
cell
Control
(-595)
Experimental
(+595) Ratio
I ER 18 24 1 .3
RST 11 27 2 .5
RSV40 4 11 2 .6
2 ER 20 33 1 .6
RST 9 .7 22 2 .2
RSV40 4 .5 12 2 .6that bacterial glycolipid can bind to the cell
membrane.
Although at present we do not know whether
there are specific receptors for bacterial glycolipids
on the cell membrane, it is nevertheless apparent
that the binding of the bacterial glycolipid to
either the lipid bilayer or to a membrane-associ-
ated protein alters the activity of the membrane-
bound adenyl cyclase-cyclic AMP phosphodiester-
ase system such that the intracellular concentration
of cyclic AMP is enhanced . Because of the known
growth inhibitory effect of dibutyryl cyclic AMP
on transformed cultured cells, we tend to believe
that the mechanism of action of bacterial glyco-
lipid-mediated inhibition of transformed cells is
due to the increase of the intracellular level of
cyclic AMP. Our future work on the isolation of
bacterial glycolipid receptors in isolated cell mem-
branes from normal and transformed cells as well
as on the alterations in the activities of membrane-
bound adenyl cyclase-cyclic AMP phosphodiester-
ase is likely to throw light on the mode of action
of bacterial glycolipids on normal and transformed
cultured cells .
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